| |
| |
|
| Insider
Information: |
Swartz Robin |
| Relationship: |
Chief Operating Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
117,004 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,002,724 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
117,004 |
|
|
| Total
Value |
$1,002,724 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Voyager Therapeutics, Inc. |
VYGR |
Chief Operating Officer |
2024-04-02 |
117,004 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2024-04-02 |
4 |
S |
$9.88 |
$13,407 |
D/D |
(1,357) |
117,004 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2024-02-21 |
4 |
S |
$7.45 |
$29,547 |
D/D |
(3,966) |
118,361 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2024-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
122,327 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2024-01-17 |
4 |
S |
$7.15 |
$18,182 |
D/D |
(2,543) |
72,327 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2023-04-03 |
4 |
S |
$7.83 |
$9,858 |
D/D |
(1,259) |
71,617 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2023-03-20 |
4 |
AS |
$7.76 |
$28,355 |
D/D |
(3,654) |
72,876 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2023-03-15 |
4 |
S |
$8.20 |
$126,059 |
D/D |
(15,373) |
76,530 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2023-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
91,903 |
0 |
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2023-01-17 |
4 |
AS |
$9.57 |
$21,549 |
D/D |
(2,188) |
51,903 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2022-04-04 |
4 |
AS |
$8.25 |
$12,598 |
D/D |
(1,527) |
52,060 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating Officer |
• – – |
2022-03-21 |
4 |
AS |
$8.29 |
$36,604 |
D/D |
(4,413) |
53,587 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
Chief Operating OfficerOfficer |
• – – |
2022-02-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
58,000 |
|
% |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
